Biggest News Aggregation in the World
📰 Ebsite Design News

Page 46 - Ebsite Design News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ebsite Design. Real-time updates on events, politics, business and more.

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases

<ul> <li> Secarnas LNAplus™ ASOs suppress expression of NLRP3, a central component of the inflammasome pathway, which is overactive in many inflammatory diseases </li> <li> Cryopyrin-associated periodic syndrome (CAPS) is a group of rare inherited autoinflammatory diseases driven by overactive NLRP3, resulting in systemic inflammation </li> <li> With NLRP3-specific ASOs, inflammatory downstream effects were interrupted in immune cells a...
Frank Jaschinski Ariel Feldstein Secarna Lnaplus Hal Hoffman Secarna Pharmaceuticals Secarna Pharmaceuticals Gmbh Co

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science